Skip to main content
. 2021 Sep 5;10(4):1015–1024. doi: 10.1007/s40123-021-00395-6

Fig. 2.

Fig. 2

Comparison in the proportion of eyes achieving a best corrected visual acuity (BCVA) improvement of ≥ 5, ≥ 10, and ≥ 15 letters and a BCVA loss of ≥ 5, ≥ 10, and ≥ 15 letters in the dexamethasone intravitreal (DEX) implant and anti-VEGF groups. ns No significant difference